secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0000950170-24-023918
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics doubles Executive Chair salary to $400k retroactive to Jan 1, 2024
--------------------------------------------------------------------------------

- Board approved salary increase for Executive Chair Harlan Waksal from $200k to $400k annually.
- Increase is retroactive to January 1, 2024.
- No other compensation changes for officers were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000095017024023918/0000950170-24-023918-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000095017024023918/lyra-20240226.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-023918

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer